These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7511893)

  • 41. Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells.
    Barry EL; Viglione MP; Kim YI; Froehner SC
    J Neurosci; 1995 Jan; 15(1 Pt 1):274-83. PubMed ID: 7823133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenic osteomalacia.
    Weiss D; Bar RS; Weidner N
    Ann Intern Med; 1985 Apr; 102(4):557. PubMed ID: 2983596
    [No Abstract]   [Full Text] [Related]  

  • 43. Peptide neurotoxins, small-cell lung carcinoma andneurological paraneoplastic syndromes.
    Sher E; Giovannini F; Boot J; Lang B
    Biochimie; 2000; 82(9-10):927-36. PubMed ID: 11086222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new paraneoplastic encephalomyelitis autoantibody reactive with the axon initial segment.
    Shams'ili S; de Leeuw B; Hulsenboom E; Jaarsma D; Smitt PS
    Neurosci Lett; 2009 Dec; 467(2):169-72. PubMed ID: 19833174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy.
    Kikuchi T; Arai J; Shibuki H; Kawashima H; Yoshimura N
    J Neuroimmunol; 2000 Feb; 103(1):26-33. PubMed ID: 10674986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantigen discovery with a synthetic human peptidome.
    Larman HB; Zhao Z; Laserson U; Li MZ; Ciccia A; Gakidis MA; Church GM; Kesari S; Leproust EM; Solimini NL; Elledge SJ
    Nat Biotechnol; 2011 May; 29(6):535-41. PubMed ID: 21602805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration.
    Musunuru K; Darnell RB
    Annu Rev Neurosci; 2001; 24():239-62. PubMed ID: 11283311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the Alternative Neural Transcriptome by ELAV/Hu RNA Binding Proteins.
    Wei L; Lai EC
    Front Genet; 2022; 13():848626. PubMed ID: 35281806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development.
    Cheng K; Wang Y; Zhou Y; Xia R; Tang L; Liu J
    Clin Med Insights Oncol; 2021; 15():11795549211056261. PubMed ID: 34866959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The neurogenetics of alternative splicing.
    Vuong CK; Black DL; Zheng S
    Nat Rev Neurosci; 2016 May; 17(5):265-81. PubMed ID: 27094079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.
    Gerstberger S; Hafner M; Ascano M; Tuschl T
    Adv Exp Med Biol; 2014; 825():1-55. PubMed ID: 25201102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction.
    Bronicki LM; Jasmin BJ
    RNA; 2013 Aug; 19(8):1019-37. PubMed ID: 23861535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
    Kazarian M; Laird-Offringa IA
    Mol Cancer; 2011 Mar; 10():33. PubMed ID: 21450098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examination of the expanding pathways for the regulation of p21 expression and activity.
    Jung YS; Qian Y; Chen X
    Cell Signal; 2010 Jul; 22(7):1003-12. PubMed ID: 20100570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRNA stability and the control of gene expression: implications for human disease.
    Hollams EM; Giles KM; Thomson AM; Leedman PJ
    Neurochem Res; 2002 Oct; 27(10):957-80. PubMed ID: 12462398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complex formation of the neuron-specific ELAV-like Hu RNA-binding proteins.
    Kasashima K; Sakashita E; Saito K; Sakamoto H
    Nucleic Acids Res; 2002 Oct; 30(20):4519-26. PubMed ID: 12384599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells.
    Mobarak CD; Anderson KD; Morin M; Beckel-Mitchener A; Rogers SL; Furneaux H; King P; Perrone-Bizzozero NI
    Mol Biol Cell; 2000 Sep; 11(9):3191-203. PubMed ID: 10982410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems.
    Akamatsu W; Okano HJ; Osumi N; Inoue T; Nakamura S; Sakakibara S; Miura M; Matsuo N; Darnell RB; Okano H
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9885-90. PubMed ID: 10449789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells.
    Aranda-Abreu GE; Behar L; Chung S; Furneaux H; Ginzburg I
    J Neurosci; 1999 Aug; 19(16):6907-17. PubMed ID: 10436048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmunity in paraneoplastic neurological syndromes.
    Giometto B; Taraloto B; Graus F
    Brain Pathol; 1999 Apr; 9(2):261-73. PubMed ID: 10219744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.